Galectin-3 is a presurgical marker of human thyroid carcinoma

被引:0
|
作者
Orlandi, F
Saggiorato, E
Pivano, G
Puligheddu, B
Termine, A
Cappia, S
De Giuli, P
Angeli, A
机构
[1] Univ Turin, Dept Clin & Biol Sci, I-10043 Torino, Italy
[2] San Luigi Hosp, Dept Pathol, I-10043 Torino, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Galectin-3 is a carbohydrate-binding protein endon ed with an affinity for beta-galactosides. It has been shown to play an important role in cell-cell and cell-matrix interactions and in pre-mRNA splicing. Furthermore, it is involved in the control of cell growth, neoplastic transformation, and metastasis. Interestingly, high levels of galectin-3 expression have been recently described in malignant thyroid neoplasias, but not in adenomas or in normal thyroid tissue. We investigated galectin-3 expression in human presurgical specimens obtained by fine-needle aspiration biopsy. We analyzed galectin-3 expression by immunoperoxidase staining in both paraffin-embedded cytological thyroid sediments (cell blocks) obtained by Fine-needle aspiration biopsy and their histological counterparts. A total of 64 samples were examined: 17 follicular carcinomas; 18 papillary carcinomas; and 29 follicular adenomas. All cell blocks and histological samples of papillary carcinomas expressed high levels of galectin-3 at either the cytoplasmic or nuclear level. Among follicular carcinomas, all histological samples expressed galectin-3, whereas 1 1 of 17 corresponding cell blocks were positive in the cytoplasm. No evidence of cytoplasmic galectin-3 expression was observed in 26 of 29 follicular adenomas. Hence, cytoplasmic galectin-3 staining seems to be a reliable, easy, and cheap marker for presurgical diagnosis of follicular carcinomas and an even more suitable one for papillary carcinomas.
引用
收藏
页码:3015 / 3020
页数:6
相关论文
共 50 条
  • [11] Expression of galectin-1 and galectin-3 in human fetal thyroid gland
    Savin, SB
    Cvejic, DS
    Jankovic, MM
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (04) : 479 - 483
  • [12] Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells
    Harazono, Yosuke
    Kho, Dhong Hyo
    Balan, Vitaly
    Nakajima, Kosei
    Zhang, Tianpeng
    Hogan, Victor
    Raz, Avraham
    ONCOTARGET, 2014, 5 (20) : 9992 - 10001
  • [13] Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis
    Tang, Weiwei
    Huang, Congwei
    Tang, Chongyin
    Xu, Jin
    Wang, Hanjin
    ONCOTARGETS AND THERAPY, 2016, 9 : 455 - 460
  • [14] Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions
    Oestreicher-Kedem, Y
    Halpern, M
    Roizman, P
    Hardy, B
    Sulkes, J
    Feinmesser, R
    Stern, Y
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (11): : 960 - 966
  • [15] Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells
    Yoshii, T
    Inohara, H
    Takenaka, Y
    Honjo, Y
    Akahani, S
    Nomura, T
    Raz, A
    Kubo, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (04) : 787 - 792
  • [16] Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid
    Manivannan, Prabhu
    Siddaraju, Neelaiah
    Jatiya, Lakshmi
    Verma, Surendra Kumar
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2012, 49 (05): : 392 - 394
  • [17] Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents
    Niedziela, M
    Maceluch, J
    Korman, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4411 - 4415
  • [18] Galectin-3 Expression in Tumor Progression and Metastasis of Papillary Thyroid Carcinoma
    Hüseyin K. Türköz
    Hülya Öksüz
    Ziya Yurdakul
    Deniz Özcan
    Endocrine Pathology, 2008, 19 : 92 - 96
  • [19] Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma
    Tuerkoez, Hueseyin K.
    Oeksuez, Huelya
    Yurdakul, Ziya
    Oezcan, Deniz
    ENDOCRINE PATHOLOGY, 2008, 19 (02) : 92 - 96
  • [20] Usefulness of galectin-3 expression in the clinical behavior of differentiated thyroid carcinoma
    Lopez Mondejar, Pedro
    Pico, Antonio
    Segui, Javier
    Lopez Macia, Alicia
    MEDICINA CLINICA, 2008, 130 (05): : 161 - 164